METHODS AND SYSTEMS FOR ELECTRONIC COMMERCE VERIFICATION
    14.
    发明申请
    METHODS AND SYSTEMS FOR ELECTRONIC COMMERCE VERIFICATION 审中-公开
    电子商务验证的方法和系统

    公开(公告)号:WO2012141845A1

    公开(公告)日:2012-10-18

    申请号:PCT/US2012/029511

    申请日:2012-03-16

    CPC classification number: G06Q20/4014 G06Q20/4016

    Abstract: A computer system for fraud detection in a payment card transaction system is provided. The computer system is programmed to receive a card transaction authorization request message for a payment card transaction initiated with a merchant that includes a plurality of data elements to be verified and a verification request indicator, determine whether the verification request indicator is valid, transmit the request message and verification request indicator to an issuer associated with the payment card, and receive a card transaction authorization response message from the issuer that includes an issuer authorization decision and a verification indicator associated with each data element verified by the issuer. The verification indicator indicates a status of a verification of the data element with data stored in one or more databases of the issuer. The computer system is further programmed to transmit the card transaction authorization response message to the merchant.

    Abstract translation: 提供了一种用于支付卡交易系统中的欺诈检测的计算机系统。 计算机系统被编程为接收用于包括要被验证的多个数据元素和验证请求指示符的商家发起的支付卡交易的卡交易授权请求消息,确定验证请求指示符是否有效,发送请求 消息和验证请求指示符发送到与支付卡相关联的发行者,并且从发行方接收包括与发行方验证的每个数据元素相关联的发行者授权决定和验证指示符的卡交易授权响应消息。 验证指示符指示利用存储在发行者的一个或多个数据库中的数据对数据元素进行验证的状态。 计算机系统进一步被编程为向商家传送卡交易授权响应消息。

    METHODS AND SYSTEMS FOR MANAGING MERCHANT IDENTIFIERS

    公开(公告)号:WO2009111562A3

    公开(公告)日:2009-09-11

    申请号:PCT/US2009/036029

    申请日:2009-03-04

    Abstract: A method and system for processing a merchant identification request from a private label payment card issuer is provided. The issuer is communicatively coupled to a multi-party payment card interchange that includes access to a database. The database stores a plurality of historical multi-party payment card transactions. The method includes transmitting a list of private label merchant locations from the issuer to the interchange wherein the list includes physical location information relating to the private label merchants listed, processing the list at the interchange by applying thereto an identification analysis including one of merchant matching only, test transaction only, and merchant matching plus test transaction, identifying at least one private label merchant location included within the list including associating a unique identifier with the at least one identified private label merchant location, and outputting the at least one identified private label merchant location with the associated unique identifier.

    PHARMACEUTICAL FORMULATIONS FOR THE CONTROLLED RELEASE OF 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL) QUINAZOLINE
    19.
    发明申请
    PHARMACEUTICAL FORMULATIONS FOR THE CONTROLLED RELEASE OF 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL) QUINAZOLINE 审中-公开
    用于控制释放4-氨基-6,7-二甲氧基-2-(5-甲磺酰氨基-1,2,3,4-四氢喹啉-2-基)-5-(2-吡啶基)喹唑啉的药物制剂

    公开(公告)号:WO2003032956A1

    公开(公告)日:2003-04-24

    申请号:PCT/IB2002/004040

    申请日:2002-09-30

    CPC classification number: A61K9/0004 A61K9/2013 A61K9/2054 A61K9/5026

    Abstract: The invention provides a controlled-release pharmaceutical formulation for oral administration comprising 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable adjuvant, diluent or carrier; characterized in that the formulation is adapted to release at least 50% by weight of the 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)-quinazoline, or the pharmaceutically acceptable salt thereof, after 6 hours in Apparatus 1 described in the United States Pharmacopoeia 24 (2000), pp 1941-1943, having 1 litre vessels, baskets of 40 mesh (0.4 mm apertures), a rotation speed of 100 rpm, and a dissolution medium consisting of 900 ml of 0.01 M hydrochloric acid containing 0.7% w/v sodium chloride at 37 °C. Formulations according to the invention are suitable for the treatment of BPH.

    Abstract translation: 本发明提供用于口服给药的控释药物制剂,其包含4-氨基-6,7-二甲氧基-2-(5-甲磺酰氨基-1,2,3,4-四氢异喹啉-2-基)-5-(2- 吡啶基)喹唑啉或其药学上可接受的盐; 和药学上可接受的佐剂,稀释剂或载体; 其特征在于该制剂适于释放至少50重量%的4-氨基-6,7-二甲氧基-2-(5-甲磺酰氨基-1,2,3,4-四氢异喹啉-2-基)-5 - (2-吡啶基) - 喹唑啉或其药学上可接受的盐,在美国药典24(2000),第1941-1943页描述的装置1中6小时后,具有1升容器,40目的篮子(0.4mm 孔径),旋转速度为100rpm,以及在37℃下由900ml含有0.7%w / v氯化钠的0.01M盐酸组成的溶解介质,适用于治疗BPH。

Patent Agency Ranking